We have identified 47 global erythropoietin tenders from the public procurement domain worldwide. View the latest global tenders for erythropoietin from Africa, the Americas, Asia, Australia, Europe, the Middle East, and other countries. Find global tender information, RFPs, RFQs, ICBs, bidding contracts, and invitations to bid for erythropoietin tenders published by various government departments, the World Bank, the United Nations, multilateral funding agencies, military, defense, and private companies across the world.
Bids Are Invited For The Purpose Of This Electronic Auction Is Standardized Medicines, Through The Price Registration System, For A Period Of 12 (Twelve) Months, And The Price Registration Minutes May Be Extended, In Whole Or In Part, Up To The Limit Established In The Internal Bidding Regulations Of Grupo Hospitalar Conceição, By Agreement Between The Parties, For Grupo Hospitalar Conceição S.A. And Branches, According To The Specifications And Conditions Contained In This Notice And Its Annexes.
Tenders Are Invited For Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Epoetin Alfa (Genetically Engineered Human Erythropoietin - Limitation To Packs With A Dosage Of Up To 10,000 Iu)
Tenders Are Invited For Pharmaceutical Products – Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin)
Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Erythropoietin Exclusively Epoetin Alfa, (Obo) Atc B03xa01 For The Period March 1St, 2025 - February 28Th, 2027
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/S/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/S/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure
